Cocrystal Pharma, Inc. - Form 8-K Summary
Business Context and Reporting Period
Cocrystal Pharma, Inc., a Delaware corporation, filed this Current Report on Form 8-K on March 13, 2019. The report addresses the closing of a previously announced private placement transaction.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses solely on the confirmation of a financing event.
Material Changes
On March 13, 2019, the Company closed a private placement with three institutional investors. This event was previously announced in a Form 8-K filed on March 11, 2019.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies beyond the confirmation of the capital raise.
Investor Verification Checklist
- Verify the total capital raised and the specific terms of the private placement with the three institutional investors.
- Review the Form 8-K filed on March 11, 2019, for detailed terms of the offering.
- Confirm the impact of this financing on the Company's cash position and runway.